Hiroko Ishida

2.3k total citations · 1 hit paper
28 papers, 1.8k citations indexed

About

Hiroko Ishida is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Hiroko Ishida has authored 28 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Medicine, 9 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Hiroko Ishida's work include Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cancer therapeutics and mechanisms (4 papers). Hiroko Ishida is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cancer therapeutics and mechanisms (4 papers). Hiroko Ishida collaborates with scholars based in Japan, United States and Sweden. Hiroko Ishida's co-authors include Kazuki Hoshino, Mark S. Warren, Olga Lomovskaya, Ving J. Lee, Suzanne Chamberland, Roger Léger, Scott J. Hecker, Johanne Blais, W. J. Watkins and May Lee and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Hiroko Ishida

27 papers receiving 1.7k citations

Hit Papers

Identification and Characterization of Inhibitors of Mult... 2001 2026 2009 2017 2001 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy
    2001 731 citations Olga Lomovskaya, Mark S. Warren et al. Antimicrobial Agents and Chemotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroko Ishida Japan 16 1.1k 783 478 295 233 28 1.8k
Nicola Franceschini Italy 21 1.2k 1.1× 685 0.9× 391 0.8× 311 1.1× 98 0.4× 68 1.7k
Charles R. Dean United States 26 899 0.8× 977 1.2× 252 0.5× 171 0.6× 100 0.4× 52 2.0k
Mei‐Ling Han Australia 26 673 0.6× 888 1.1× 309 0.6× 170 0.6× 79 0.3× 67 1.8k
Beibei Liang China 20 800 0.7× 619 0.8× 243 0.5× 223 0.8× 136 0.6× 59 1.7k
Giuseppe Celenza Italy 26 635 0.6× 619 0.8× 258 0.5× 236 0.8× 65 0.3× 80 1.8k
E Y Ng United States 11 607 0.6× 569 0.7× 449 0.9× 178 0.6× 57 0.2× 12 1.2k
A Oratore Italy 16 453 0.4× 429 0.5× 170 0.4× 185 0.6× 52 0.2× 83 985
Maria Visalli Italy 24 375 0.4× 765 1.0× 168 0.4× 151 0.5× 116 0.5× 49 1.6k
Xiaofei Jiang China 25 1.1k 1.0× 892 1.1× 227 0.5× 367 1.2× 45 0.2× 54 2.1k

Countries citing papers authored by Hiroko Ishida

Since Specialization
Citations

This map shows the geographic impact of Hiroko Ishida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Ishida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Ishida more than expected).

Fields of papers citing papers by Hiroko Ishida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Ishida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Ishida. The network helps show where Hiroko Ishida may publish in the future.

Co-authorship network of co-authors of Hiroko Ishida

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroko Ishida. A scholar is included among the top collaborators of Hiroko Ishida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroko Ishida. Hiroko Ishida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimizu, Yoshinaka, Yujiro Suzuki, Yusuke Furukawa, et al.. (2011). Pituitary adenylatecyclase-activating polypeptide-immunoreactive nerve fibers in the rat epiglottis and pharynx. Annals of Anatomy - Anatomischer Anzeiger. 193(6). 494–499. 9 indexed citations
2.
Ishida, Hiroko, et al.. (2009). [Use of argatroban during cardiopulmonary bypass for atrial septal defect with heparin induced thrombocytopenia after introduction of dialysis].. PubMed. 62(2). 122–4. 2 indexed citations
3.
Nakayama, Kiyoshi, Masami Ohtsuka, Yoshihiro Yokomizo, et al.. (2004). MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 4: Addressing the problem of poor stability due to photoisomerization of an acrylic acid moiety. Bioorganic & Medicinal Chemistry Letters. 14(10). 2493–2497. 43 indexed citations
4.
Nakayama, Kiyoshi, Yohei Ishida, Masami Ohtsuka, et al.. (2003). MexAB-OprM-Specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 1: Discovery and early strategies for lead optimization. Bioorganic & Medicinal Chemistry Letters. 13(23). 4201–4204. 66 indexed citations
5.
Nakayama, Kiyoshi, Yohei Ishida, Masami Ohtsuka, et al.. (2003). MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 2: achieving activity in vivo through the use of alternative scaffolds. Bioorganic & Medicinal Chemistry Letters. 13(23). 4205–4208. 48 indexed citations
6.
Nakayama, Kiyoshi, Haruko C. Kawato, Jun Watanabe, et al.. (2003). MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 3: Optimization of potency in the pyridopyrimidine series through the application of a pharmacophore model. Bioorganic & Medicinal Chemistry Letters. 14(2). 475–479. 55 indexed citations
7.
Lomovskaya, Olga, Mark S. Warren, Angela Lee, et al.. (2001). Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa : Novel Agents for Combination Therapy. Antimicrobial Agents and Chemotherapy. 45(1). 105–116. 731 indexed citations breakdown →
8.
Ishida, Hiroko, et al.. (1998). In Vitro and In Vivo Activities of Levofloxacin against Biofilm-Producing Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 42(7). 1641–1645. 113 indexed citations
9.
Kikuchi, Kaoru, Hiroko Ishida, & Tōru Kimura. (1997). Molecular cloning of a novel member of semaphorin family genes, semaphorin Z. Molecular Brain Research. 51(1-2). 229–237. 23 indexed citations
10.
11.
Hashimoto, Kazuhito, Mitsuhide Noshiro, Shigeru Ohno, et al.. (1997). Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/βig-h3) that binds to collagen1The nucleotide sequence data reported in this paper will appear in the EMBL, GenBank and DDBJ Nucleotide Sequence Databases under the accession number D55717.1. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1355(3). 303–314. 139 indexed citations
12.
Eggertsen, Gösta, Maria Olin, Jan Andersson, et al.. (1996). Molecular Cloning and Expression of Rabbit Sterol 12α-Hydroxylase. Journal of Biological Chemistry. 271(50). 32269–32275. 59 indexed citations
13.
Tanaka, Mayumi, Kazuki Hoshino, Hiroko Ishida, et al.. (1996). Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method. Journal of Antimicrobial Chemotherapy. 37(6). 1091–1102. 13 indexed citations
14.
Tanaka, M, et al.. (1995). Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China. Journal of Medical Microbiology. 42(3). 214–219. 28 indexed citations
15.
Ishida, Hiroko, Mitsuhide Noshiro, Kyuichiro Okuda, & Minor J. Coon. (1992). Purification and characterization of 7α-hydroxy-4-cholesten-3-one 12α-hydroxylase. Journal of Biological Chemistry. 267(30). 21319–21323. 17 indexed citations
16.
Ishida, Hiroko, M. Noshiro, K Okuda, & M J Coon. (1992). Purification and characterization of 7 alpha-hydroxy-4-cholesten-3-one 12 alpha-hydroxylase.. Journal of Biological Chemistry. 267(30). 21319–21323. 27 indexed citations
17.
Maeda, Toshio, Hiroko Ishida, Hiroshi Matsuda, et al.. (1984). The utility of radionuclide myelography and cisternography in the progress of cerebrospinal fluid leaks. European Journal of Nuclear Medicine and Molecular Imaging. 9(9). 416–418. 6 indexed citations
18.
Saito, Yumiko, et al.. (1982). Toxic Effects and Changes of Blood Components by Photodynamic Action Induced by Pheophorbide-a in Rats. Food Hygiene and Safety Science (Shokuhin Eiseigaku Zasshi). 23(5). 365–372_1. 3 indexed citations
19.
Ohtani, Iwao, et al.. (1974). Experimental Study on the Effect of Thiamine Derivative upon the Kanamycin Ototoxicity. ORL. 36(6). 344–354. 1 indexed citations
20.
Watanabe, Shiro, et al.. (1969). [Studies on josamycin. 3. (1) Bacteriological studies. (2) Protective effect against infections due to pathogenic bacteria. (3) Absorption, excretion, distribution in organs and in vivo activities].. PubMed. 22(2). 159–72. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Franceschini Breakdown of academic impact, for papers by Charles R. Dean Breakdown of academic impact, for papers by Mei‐Ling Han Breakdown of academic impact, for papers by Beibei Liang Breakdown of academic impact, for papers by Giuseppe Celenza Breakdown of academic impact, for papers by E Y Ng Breakdown of academic impact, for papers by A Oratore Breakdown of academic impact, for papers by Maria Visalli Breakdown of academic impact, for papers by Xiaofei Jiang
Rankless by CCL
2026